Search Results 1501-1510 of 16409 for monoclonal antibody

1. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

   Hepatitis C virus (HCV) antibody positive; Use of moderate/strong cytochrome P450 (CYP)3A4 inhibitors or moderate/strong CYP3A4 inducers within 2 weeks prior ...

2. An Effectiveness and Safety Study of Daratumumab in Relapsed/Resistant Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma - Mayo Clinic

   Antibody within 4 weeks. Daratumumab or other anti-CD38 therapies; Participant has a history of malignancy (other than NHL) within 5 years before the ...

3. A Study of the Effectiveness and Safety of CTL019 in Adult Patients with Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Antibody use including anti-CD20 therapy within 4 weeks prior to infusion or 5 half-lives of the respected antibody, whichever is longer; CNS disease ...

4. Drug Allergy Clinical Trials - Mayo Clinic Research

   The purpose of this study is to evaluate a serum IgE hemp antibody immunoassay for use in the evaluation of allergies to cannabis and other hemp products.

5. Herd immunity, antibodies & COVID-19 / bile duct cancer / peripheral artery disease - Mayo Clinic News Network

   Herd immunity, antibodies & COVID-19 / bile duct cancer / peripheral artery disease. 00:00. |. Herd immunity, antibodies & COVID-19 / bile duct cancer / ...

6. A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 in Amyotrophic Lateral Sclerosis (ALS) Patients - Mayo Clinic

   Current hepatitis C infection (defined as positive hepatitis C virus [HCV] antibody and detectable HCV RNA). Participants with positive HCV antibody and ...

7. Risk Factors Associated with Clustered Plasma Cell Dyscrasias in Minnesota - Mayo Clinic

   Confirmed diagnosis of multiple myeloma (MM), Waldenstrom macroglobulinemia (WM) or monoclonal gammopathy of undetermined significance (MGUS); Agreement in ...

8. 7T MR Imaging in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE) - Mayo Clinic

   Detection of clinically relevant donor-specific allo-Human Leukocyte Antigen (HLA) reactive antibodies ... Clinical diagnosis of autoimmune epilepsy, supported by ...

9. Collaborative programs - Center for Multiple Sclerosis and Autoimmune Neurology - Mayo Clinic Research

   ... autoantibody profiles. The lab seeks to define neuronal muscle and glial antigens and investigates immunopathological mechanisms of neurological disease ...

10. XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia - Mayo Clinic

    surface antibody) must have an undetectable hepatitis B viral load. Subjects who have positive hepatitis C antibody may be included if they have an ...